NCT04585750 2026-03-12The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PMV Pharmaceuticals, IncPhase 1/2 Recruiting300 enrolled
NCT05000294 2026-02-18Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Suspended29 enrolled
NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT07319767 2026-01-06Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant TumorsShanghai Zhongshan HospitalCompleted120 enrolled